Preneau S, Dreno B. Female acne – a different subtype of teenager acne? J Eur Acad Dermatol Venereol 2012; 26: 277-282.
https://doi.org/10.1111/j.1468-3083.2011.04214.x DOI: https://doi.org/10.1111/j.1468-3083.2011.04214.x
Dreno B, Thiboutot D, Layton AM, Berson D, Perez M, Kang S. Large-scale international study enhances understanding of an emerging acne population: adult females. J Eur Acad Dermatol Venereol 2015; 29: 1096-1106.
https://doi.org/10.1111/jdv.12757 DOI: https://doi.org/10.1111/jdv.12757
Branisteanu DE, Toader MP, Porumb EA, Serban IL, Pinzariu AC, Branisteanu CI, et al. Adult female acne: Clinical and therapeutic particularities (Review). Exp Ther Med 2022; 23: 151. DOI: https://doi.org/10.3892/etm.2022.11184
https://doi.org/10.3892/etm.2021.11074 DOI: https://doi.org/10.3892/etm.2021.11074
Poli F, Dreno B, Verschoore M. An epidemiological study of acne in female adults: results of a survey conducted in France. J Eur Acad Dermatol Venereol 2001; 15: 541-545.
https://doi.org/10.1046/j.1468-3083.2001.00357.x DOI: https://doi.org/10.1046/j.1468-3083.2001.00357.x
Dréno B, Dagnelie MA, Khammari A, Corvec S. The skin microbiome: a new actor in inflammatory acne. Am J Clin Dermatol 2020; 21: 18-24.
https://doi.org/10.1007/s40257-020-00531-1 DOI: https://doi.org/10.1007/s40257-020-00531-1
Dreno B, Thiboutot D, Gollnick H, Bettoli V, Kang S, Leyden JJ, et al. Antibiotic stewardship in dermatology: limiting antibiotic use in acne. Eur J Dermatol 2014; 24: 330-334.
https://doi.org/10.1684/ejd.2014.2309 DOI: https://doi.org/10.1684/ejd.2014.2309
Castellanos Lorduy HJ, Pérez Cely HC, Casadiego Rincón EJ, Henao Riveros SC, Colorado CL. Cutibacterium acnes tetracycline resistance profile in patients with acne vulgaris, in a Colombian Dermatologic Center. Actas Dermosifiliogr (Engl Ed) 2021 May 19: S0001-7310(21)00191-5
Leclerc-Mercier S, Buisson V, Dreno B. New regulations for oral contraceptive prescription in France in 2013: what is the impact on adult female acne? Eur J Dermatol 2016; 26: 345-349.
https://doi.org/10.1684/ejd.2016.2773 DOI: https://doi.org/10.1684/ejd.2016.2773
Barbieri JS, Spaccarelli N, Margolis DJ, James WD. Approaches to limit systemic antibiotic use in acne: Systemic alternatives, emerging topical therapies, dietary modification, and laser and light-based treatments. J Am Acad Dermatol 2019; 80: 538-549.
https://doi.org/10.1016/j.jaad.2018.09.055 DOI: https://doi.org/10.1016/j.jaad.2018.09.055
Moore A, Ling M, Bucko A, Manna V, Rueda MJ. Efficacy and safety of subantimicrobial dose, modified-release doxycycline 40 mg versus doxycycline 100 mg versus placebo for the treatment of inflammatory lesions in moderate and severe acne: a randomized, double-blinded, controlled study. J Drugs Dermatol 2015; 14: 581-586.
Xem thêm : How to apply for a controlled hunt
Nast A, Dreno B, Bettoli V, Bukvic Mokos Z, Degitz K, Dressler C, et al. European evidence-based (S3) guideline for the treatment of acne – update 2016 – short version. J Eur Acad Dermatol Venereol 2016; 30: 1261-1268.
https://doi.org/10.1111/jdv.13776 DOI: https://doi.org/10.1111/jdv.13776
Zaenglein AL, Pathy AL, Schlosser BJ, Alikhan A, Baldwin HE, Berson DS, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol 2016; 74: 945-973.e33.
https://doi.org/10.1016/j.jaad.2015.12.037
[No authors listed] Spironolactone. Brit Med J 1967; 2: 751.
https://doi.org/10.1136/bmj.2.5554.751 DOI: https://doi.org/10.1136/bmj.2.5554.751
Akamatsu H, Zouboulis CC, Orfanos CE. Spironolactone directly inhibits proliferation of cultured human facial sebocytes and acts antagonistically to testosterone and 5 alpha-dihydrotestosterone in vitro. J Invest Dermatol 1993; 100: 660-662.
https://doi.org/10.1111/1523-1747.ep12472325 DOI: https://doi.org/10.1111/1523-1747.ep12472325
Han JJ, Faletsky A, Barbieri JS, Mostaghimi A. New acne therapies and updates on use of spironolactone and isotretinoin: a narrative review. Dermatol Ther 2021; 11: 79-91.
https://doi.org/10.1007/s13555-020-00481-w DOI: https://doi.org/10.1007/s13555-020-00481-w
Carmina E, Dreno B, Lucky WA, Agak WG, Dokras A, Kim JJ, et al. Female Adult acne and androgen excess: a report from the Multidisciplinary Androgen Excess and PCOS Committee. J Endocr Soc 2022; 6: bvac003.
https://doi.org/10.1210/jendso/bvac003 DOI: https://doi.org/10.1210/jendso/bvac003
Zaenglein AL, Pathy AL, Schlosser BJ, Alikhan A, Baldwin HE, Berson DS, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol 2016; 74: 945-973.e33.
https://doi.org/10.1016/j.jaad.2015.12.037 DOI: https://doi.org/10.1016/j.jaad.2015.12.037
Poinas A, Lemoigne M, Le Naour S, Nguyen JM, Schirr-Bonnans S, Riche VP, et al. FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial. Trials 2020; 21: 571.
https://doi.org/10.1186/s13063-020-04432-w DOI: https://doi.org/10.1186/s13063-020-04432-w
Auffret N, Claudel JP, Leccia MT, Poli F, Farhi D, Dréno B. AFAST – Adult Female Acne Scoring Tool: an easy-to-use tool for scoring acne in adult females. J Eur Acad Dermatol Venereol 2016; 30: 824-828.
https://doi.org/10.1111/jdv.13518 DOI: https://doi.org/10.1111/jdv.13518
Cooper DB, Patel P, Mahdy H. Oral contraceptive pills. Treasure Island, FL: StatPearls Publishing LLC, 2023.
Dreno B, Poli F, Pawin H, Beylot C, Faure M, Chivot M, et al. Development and evaluation of a Global Acne Severity Scale (GEA Scale) suitable for France and Europe. J Eur Acad Dermatol Venereol 2011; 25: 43-48.
https://doi.org/10.1111/j.1468-3083.2010.03685.x DOI: https://doi.org/10.1111/j.1468-3083.2010.03685.x
Dreno B, Bodokh I, Chivot M, Daniel F, Humbert P, Poli F, et al. La grille ECLA : un système de cotation de l’acné pour la pratique quotidienne du dermatologue. Ann Dermatol Venereol 1999; 126: 136-41.
Motley RJ, Finlay AY. Practical use of a disability index in the routine management of acne. Clin Exp Dermatol 1992; 17: 1-3.
https://doi.org/10.1111/j.1365-2230.1992.tb02521.x DOI: https://doi.org/10.1111/j.1365-2230.1992.tb02521.x
Balestroni G, Bertolotti G. [EuroQol-5D (EQ-5D): an instrument for measuring quality of life]. Monaldi Arch Chest Dis 2012; 78: 155-159 (in Italian).
Layton AM, Eady EA, Whitehouse H, Del Rosso JQ, Fedorowicz Z, van Zuuren EJ. Oral spironolactone for acne vulgaris in adult females: a hybrid systematic review. Am J Clin Dermatol 2017; 18: 169-191.
https://doi.org/10.1007/s40257-016-0245-x DOI: https://doi.org/10.1007/s40257-016-0245-x
Bienenfeld A, Nagler AR, Orlow SJ. Oral antibacterial therapy for acne vulgaris: an evidence-based review. Am J Clin Dermatol 2017; 18: 469-490.
https://doi.org/10.1007/s40257-017-0267-z DOI: https://doi.org/10.1007/s40257-017-0267-z
Isvy-Joubert A, Nguyen JM, Gaultier A, Saint-Jean M, Le Moigne M, Boisrobert E, et al. Adult female acne treated with spironolactone: a retrospective data review of 70 cases. Eur J Dermatol 2017; 27: 393-398.
https://doi.org/10.1684/ejd.2017.3062 DOI: https://doi.org/10.1684/ejd.2017.3062
Wang Y, Lipner SR. Retrospective analysis of adverse events with spironolactone in females reported to the United States Food and Drug Administration. Int J Womens Dermatol 2020; 6: 272-276.
https://doi.org/10.1016/j.ijwd.2020.05.002 DOI: https://doi.org/10.1016/j.ijwd.2020.05.002
Basu P, Elman SA, Abudu B, Beckles A, Salian P, Yanes DA, et al. High-dose spironolactone for acne in patients with polycystic ovarian syndrome: a single-institution retrospective study. J Am Acad Dermatol 2021; 85: 740-741.
https://doi.org/10.1016/j.jaad.2019.07.102 DOI: https://doi.org/10.1016/j.jaad.2019.07.102
Saint-Jean M, Ballanger F, Nguyen JM, Khammari A, Dreno B. Importance of spironolactone in the treatment of acne in adult women. J Eur Acad Dermatol Venereol 2011; 25: 1480-1481.
https://doi.org/10.1111/j.1468-3083.2010.03926.x DOI: https://doi.org/10.1111/j.1468-3083.2010.03926.x
Nguồn: https://vuihoctienghan.edu.vn
Danh mục: Info
